| Product Code: ETC6750931 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Pleural Effusion Drug Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Pleural Effusion Drug Market Revenues & Volume, 2021 & 2031F |
3.3 China Pleural Effusion Drug Market - Industry Life Cycle |
3.4 China Pleural Effusion Drug Market - Porter's Five Forces |
3.5 China Pleural Effusion Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Pleural Effusion Drug Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 China Pleural Effusion Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 China Pleural Effusion Drug Market Revenues & Volume Share, By Drug Class Type, 2021 & 2031F |
3.9 China Pleural Effusion Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 China Pleural Effusion Drug Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 China Pleural Effusion Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in China |
4.2.2 Growing aging population leading to higher incidence of pleural effusion |
4.2.3 Advancements in medical technology and treatments for pleural effusion |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for new drugs in China |
4.3.2 High cost associated with development and commercialization of pleural effusion drugs |
4.3.3 Limited awareness about pleural effusion among healthcare professionals and patients in China |
5 China Pleural Effusion Drug Market Trends |
6 China Pleural Effusion Drug Market, By Types |
6.1 China Pleural Effusion Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Pleural Effusion Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Pleural Effusion Drug Market Revenues & Volume, By Transudative Pleural Effusions, 2021- 2031F |
6.1.4 China Pleural Effusion Drug Market Revenues & Volume, By Exudative Effusions, 2021- 2031F |
6.2 China Pleural Effusion Drug Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 China Pleural Effusion Drug Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 China Pleural Effusion Drug Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.3 China Pleural Effusion Drug Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 China Pleural Effusion Drug Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 China Pleural Effusion Drug Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 China Pleural Effusion Drug Market, By Drug Class Type |
6.4.1 Overview and Analysis |
6.4.2 China Pleural Effusion Drug Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.4.3 China Pleural Effusion Drug Market Revenues & Volume, By Sclerosing Agent, 2021- 2031F |
6.4.4 China Pleural Effusion Drug Market Revenues & Volume, By Diuretics, 2021- 2031F |
6.5 China Pleural Effusion Drug Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 China Pleural Effusion Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 China Pleural Effusion Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.6 China Pleural Effusion Drug Market, By End- Users |
6.6.1 Overview and Analysis |
6.6.2 China Pleural Effusion Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Pleural Effusion Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 China Pleural Effusion Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 China Pleural Effusion Drug Market Import-Export Trade Statistics |
7.1 China Pleural Effusion Drug Market Export to Major Countries |
7.2 China Pleural Effusion Drug Market Imports from Major Countries |
8 China Pleural Effusion Drug Market Key Performance Indicators |
8.1 Number of clinical trials for pleural effusion drugs in China |
8.2 Adoption rate of minimally invasive procedures for pleural effusion treatment |
8.3 Investments in research and development for pleural effusion drugs in China |
9 China Pleural Effusion Drug Market - Opportunity Assessment |
9.1 China Pleural Effusion Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Pleural Effusion Drug Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 China Pleural Effusion Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 China Pleural Effusion Drug Market Opportunity Assessment, By Drug Class Type, 2021 & 2031F |
9.5 China Pleural Effusion Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 China Pleural Effusion Drug Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 China Pleural Effusion Drug Market - Competitive Landscape |
10.1 China Pleural Effusion Drug Market Revenue Share, By Companies, 2024 |
10.2 China Pleural Effusion Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here